Vertex Pharmaceuticals (VRTX)

Total Liabilities

$7.18B

Quarterly · Period ending: · USD

VRTX logo

VRTX Total Liabilities

Latest reported$7.18B
VRTX Quarterly Total Liabilities ($4.00M → $7.18B)
High-resolution chart · PNG

VRTX total liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Total Liabilities — Quarterly (USD)
Period endingTotal Liabilities (USD)
7,175,400,000
7,122,500,000
7,477,000,000
7,543,500,000
6,861,300,000
6,384,200,000
6,123,600,000
6,609,300,000
5,357,400,000
5,370,800,000
5,149,800,000
5,213,400,000
4,879,000,000
4,541,900,000
4,238,200,000
3,676,800,000
3,648,700,000
3,349,100,000
3,332,500,000
3,088,037,000
3,025,290,000
3,134,805,000
3,065,000,000
3,168,160,000
2,697,125,000
2,431,547,000
2,233,221,000
2,261,159,000
1,963,506,000
1,819,801,000
1,810,695,000
1,686,359,000
1,620,503,000
1,522,153,000
1,503,708,000
1,395,081,000
1,418,363,000
1,263,910,000
1,558,596,000
1,401,300,000
1,380,137,000
1,371,708,000
1,404,959,000
1,357,261,000
1,325,857,000
1,168,290,000
1,238,496,000
1,250,181,000
945,551,000
966,230,000
962,636,000
1,135,692,000
1,074,880,000
1,454,274,000
1,563,436,000
1,454,077,000
1,361,249,000
1,240,266,000
1,275,804,000
1,361,152,000
1,313,920,000
1,146,815,000
1,221,473,000
1,238,733,000
827,067,000
779,690,000
859,142,000
964,747,000
710,819,000
859,032,000
741,605,000
717,661,000
730,880,000
585,250,000
330,182,000
323,113,000
346,485,000
333,796,000
415,644,000
394,342,000
450,482,000
291,746,000
309,822,000
417,263,000
473,945,000
492,720,000
510,012,000
500,042,000
513,758,000
512,092,000
531,566,000
511,394,000
473,939,000
440,037,000
437,139,000
422,856,000
423,794,000
425,401,000
449,780,000
446,083,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.